Transparency is needed to improve equity, though it can be awkward to talk about salary, says Thomas MacGillivray.

Observational data point to the scope of opportunity that lies in GLP-1 drugs, SGLT2 inhibitors, and nonsteroidal MRAs.

The study supports “more is more” when it comes to arterial conduits until additional RCT data arrive, researcher says.

Topics spanned from GLP-1s to aorto-coronary bypass without surgery, Lp(a)’s extended reach, US dietary guidelines, and more.

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

NEW ORLEANS, LA—A risk model based on data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) ...

Cases exceeding the 90th percentile for dose, though infrequent, resulted in greater cumulative exposures for all cath lab ...

REUP avoids the ethical issues and costs of other procurement and recovery methods. So far, outcomes are excellent.

Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.

Brian Lindman and Christopher Cook review the paradigm shift from passive watchful waiting to proactive management of severe aortic stenosis.

Linda Gillam and Cynthia Taub discuss how the latest ASE guidelines are redefining the role of echocardiographers, ...

With COVID now out of the top 5, stroke has taken over the number 4 position thanks to rising death rates in young and old.